Abstract: The present invention relates to a process for the preparation of aripiprazole lauroxil. Further, the process of the present invention provides highly pure aripiprazole lauroxil. The present invention also provides a process for preparation of sterile aripiprazole lauroxil which can be directly used in the preparation of pharmaceutical formulation.
Soft Copy Attached in pdf...
| # | Name | Date |
|---|---|---|
| 1 | Form5_As Filed_11-07-2019.pdf | 2019-07-11 |
| 2 | Form3_As Filed_11-07-2019.pdf | 2019-07-11 |
| 3 | Form2 Title Page_Provisional_11-07-2019.pdf | 2019-07-11 |
| 4 | Form1_As Filed_11-07-2019.pdf | 2019-07-11 |
| 5 | Description Provisional_As Filed_11-07-2019.pdf | 2019-07-11 |
| 6 | Correspondence by Applicant_As Filed_11-07-2019.pdf | 2019-07-11 |
| 7 | 201941027825-Form5_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 8 | 201941027825-Form3_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 9 | 201941027825-Form2 Title Page_Complete_06-07-2020.pdf | 2020-07-06 |
| 10 | 201941027825-Form1_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 11 | 201941027825-Drawing_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 12 | 201941027825-Description Complete_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 13 | 201941027825-Correspondence_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 14 | 201941027825-Claims_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 15 | 201941027825-Abstract_Complete After Provisional_06-07-2020.pdf | 2020-07-06 |
| 16 | 201941027825-FORM 18 [26-05-2023(online)].pdf | 2023-05-26 |
| 17 | 201941027825-FER.pdf | 2023-09-20 |
| 18 | 201941027825-FER_SER_REPLY [10-11-2023(online)].pdf | 2023-11-10 |
| 19 | 201941027825-US(14)-HearingNotice-(HearingDate-05-01-2024).pdf | 2023-11-28 |
| 20 | 201941027825-Correspondence to notify the Controller [02-01-2024(online)].pdf | 2024-01-02 |
| 21 | 201941027825-Written submissions and relevant documents [18-01-2024(online)].pdf | 2024-01-18 |
| 22 | 201941027825-Written submissions and relevant documents [18-01-2024(online)]-1.pdf | 2024-01-18 |
| 23 | 201941027825-Proof of Right [18-01-2024(online)].pdf | 2024-01-18 |
| 24 | 201941027825-Annexure [18-01-2024(online)].pdf | 2024-01-18 |
| 25 | 201941027825-Annexure [18-01-2024(online)]-1.pdf | 2024-01-18 |
| 26 | 201941027825-US(14)-ExtendedHearingNotice-(HearingDate-28-03-2024).pdf | 2024-02-16 |
| 27 | 201941027825-Correspondence to notify the Controller [13-03-2024(online)].pdf | 2024-03-13 |
| 28 | 201941027825-US(14)-ExtendedHearingNotice-(HearingDate-03-04-2024).pdf | 2024-03-14 |
| 29 | 201941027825-Correspondence to notify the Controller [29-03-2024(online)].pdf | 2024-03-29 |
| 30 | 201941027825-Written submissions and relevant documents [12-04-2024(online)].pdf | 2024-04-12 |
| 31 | 201941027825-Annexure [12-04-2024(online)].pdf | 2024-04-12 |
| 32 | 201941027825-PatentCertificate22-04-2024.pdf | 2024-04-22 |
| 33 | 201941027825-IntimationOfGrant22-04-2024.pdf | 2024-04-22 |
| 1 | aripiprazolesearch4E_18-09-2023.pdf |